QNCX
#4407
Quince Therapeutics, Inc. - Common Stock
32.5 7 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.50%
Variación mensual
+36.05%
Variación en los últimos 6 meses
+29509.09%
Cambio anual
+1898.16%
Cierres anteriores
33.7 5
Open
32.5 7
Mínimo
32.5 7
Máximo
32.5 7
Volumen
1
Financials
- Market Capitalization 33.13 M
- Employee 38
- Founded 2012
- CEO N/A
- Website www.quincetx.com
- Headquarter California, United States
- FIGI BBG00BTK1DT8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4386 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.10 USD | -3.67% | -23.36% | -53.54% | -77.91% | 35.55 M USD | ||
| 4400 |  LITS Lite Strategy, Inc. - Common Stock | 0.99 USD | +1.02% | -3.88% | +2.06% | -66.78% | 33.68 M USD | ||
| 4425 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.02 USD | +0.99% | -2.86% | +20.00% | -1.92% | 32.07 M USD | ||
| 4427 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.73 USD | +2.82% | -3.95% | -2.67% | -31.13% | 31.75 M USD |